Werner syndrome RecQ helicase-IN-3
TAC04400
2869954-98-1
98%+
Product Unit Size Stock Prize Quantity Add To Cart
10mg In stock $498.00
25mg In stock inquiry
50mg In stock inquiry
100mg In stock inquiry
Bulk Size Bulk Discount
INQUIRY Collect products

Downloads

Description

Werner syndrome RecQ helicase-IN-3 is a potent and orally active werner syndrome recQ helicase (WRN) inhibitor with an IC50 value of 0.06 µM. Werner syndrome RecQ helicase-IN-3 shows antiproliferative activity. Werner syndrome RecQ helicase-IN-3 shows anticancer activity[1].

Product Info

Cas No. 2869954-98-1
Formula C31H30ClF3N8O5
Formula Wt. 687.07
Synonym [1,2,4]Triazolo[1,5-a]pyrimidine-4(7H)-acetamide, N-[2-chloro-4-(trifluoromethyl)phenyl]-2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-[4-[(3-hydroxy-2-pyridinyl)carbonyl]-1-piperazinyl]-7-oxo-;Werner syndrome RecQ helicase-IN-3
Solubility DMSO : 125 mg/mL (279.06 mM; ultrasonic and warming and heat to 60°C)
Appearance Solid powder.Please contact us for more accurate information.

Shipping and Storage

Store Temp Room temperature in continental US; may vary elsewhere.
Ship Temp Powder:3 years -20°C。In solvent:1 years -80°C